This invention relates to compositions and methods for the treatment excessive weight and obesity, associated metabolic and physical aberrations such as, but not limited to an altered plasma lipid profile and elevated blood pressure. In yet other embodiments, this invention relates to compositions and methods for the treatment and prevention of irritable bowel syndrome (MS).